32264-87-2Relevant articles and documents
Synthesis of cyclobuteniminium salts derived from aldo-keteniminium salts and study of their reactivity in Diels-Alder reaction
Lumbroso, Alexandre,Catak, Saron,Sulzer-Mossé, Sarah,De Mesmaeker, Alain
, p. 6721 - 6725 (2014)
The synthesis of broad scope of novel monosubstituted cyclobuteniminium salts derived from aldo-keteniminium salts and acetylene or 1-propyne is described. The reactivity of cyclobuteniminium salts in Diels-Alder reactions has been studied in detail by DF
An expedient synthesis of cis/trans-1,3-disubstituted cyclobutanols
Calad, Stacie,Mans, Douglas,Morin, Justin-Alexander,O'Neill-Slawecki, Stacy,Sisko, Joseph
scheme or table, p. 4207 - 4210 (2011/09/19)
A two-step procedure is described to access 3-alkoxycyclobutanones from chloroacetyl chloride utilizing a step-wise [2+2] ketene cycloaddition followed by catalytic hydrogenation to reduce the α-chlorine in a single reaction sequence. The resulting cyclobutanones can be readily converted into a variety of cis or trans-1,3-disubstituted aminocyclobutanols and cyclobutanediols.
Cyclobutenone as a highly reactive dienophile: Expanding upon diels-alder paradigms
Li, Xiaohua,Danishefsky, Samuel J.
supporting information; experimental part, p. 11004 - 11005 (2010/09/17)
Cyclobutenone was employed as a dienophile in Diels-Alder cycloadditions, provide diverse and complex cycloadducts in good yields. Experimental outcomes indicated cyclobutenone to be more reactive than either cyclopentenone or cyclohexenone. In addition, cycloadducts bearing a strained cyclobutanone moiety were able to undergo regioselective ring expansions to produce corresponding cyclopentanones, lactones, and lactams, which are otherwise difficultly obtained by direct Diels-Alder reactions.
BISARYLCYCLOBUTENE DERIVATES AS CYCLOOXYGENASE INHIBITORS
-
, (2008/06/13)
The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).
Process for the production of squaric acid
-
, (2008/06/13)
A process for the production of squaric acid by halogenation either of pure 3-acetoxy-2-cyclobuten-1-one or of a distillation residue of diketene production containing 3-acetoxy-2-cyclobuten-1-one to a cyclobutenone of formula: STR1 and then hydrolysis of these cyclobutenones to squaric acid. The halogenated cyclobutenones are intermediate products in the process.